Concepedia

Michael Noble

MN

2

Publications

41

Citations

2

H-Index

2006

Active since

Affiliations

GlaxoSmithKline (United Kingdom)(Current)

Michael Noble is an author at GlaxoSmithKline (United Kingdom) specializing in drug discovery, medicine, and medicinal chemistry.

Top concepts

Publications per year

2006–2008

2

Publications

2

Novel HCV NS5B polymerase inhibitors derived from 4-(1′,1′-dioxo-1′,4′-dihydro-1′λ6-benzo[1′,2′,4′]thiadiazin-3′-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 5: Exploration of pyridazinones containing 6-amino-substituents

Peter S. Dragovich, Julie Blazel, David A. Ellis et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 23 citations

, , +8

The kinetic model of the shikimate pathway as a tool to optimize enzyme assays for high‐throughput screening

Michael Noble, Yugesh Sinha, Aleksey Kolupaev et al. · Biotechnology and Bioengineering · 2006 · 18 citations

Rows per page

1–2 of 2